Similar to MRDB, this is pretty speculative. Asensus Surgical (ASXC) (~$73MM market cap) is a cash burning medical device company that makes robot systems for abdominal surgeries. Asensus has one surgical system in the market (Senhance Surgical System) and a next generation one in development (LUNA System), unfortunately for the company, they're reaching the end of their cash runway in June, per their own forecast, leaving them in a tricky spot needing to raise capital.
In comes Karl Storz SE, a privately held but sizable German medical device company, with a letter of intent to purchase Asensus for $0.35 per share (versus a $0.27 share price today), or roughly a $95MM equity check. Karl Stroz is also providing Asensus up to $20MM in a bridge financing to ensure the company has enough capital to make it to closing. The two are now in an exclusivity period and have ten weeks from 3/28 (6/6 by my math) to reach a definitive agreement. The loan distributes $1MM per week during that period and then $10MM on the signing of a definitive agreement. The spread here is pretty wide (~30%), because if Karl Storz backs away during this due diligence period, Asensus is either a zero or would need to raise equity in a punitive way. Since Karl Storz is now the senior lender, similar to MRDB, the tin hat wearer in me thinks there's a risk they could torpedo the deal and get Asensus on the cheap in distress since any other buyers are shut out during this 10 week period. There's also a non-small chance that they recut the deal for a lower price.
But Karl Storz is a legitimate buyer, most of Asensus Surgical's systems are installed in the European market, they likely have a fair amount of knowledge of the assets they're buying. This is a hard idea to size, unless you know something about the product/science (if you're one of these people, please share your thoughts below), as its challenging to handicap if this deal will go through. I added a small position.
Disclosure: I own shares of ASXC